Six proteomic clocks detect a younger biological age signal in an IPF trial – but separating geroprotection from treatment ...

PRGS&Tech is South Korea’s only team left in XPRIZE Healthspan’s $110 million race to prove a drug can help everyone age more ...

South Korean RNA-editing firm enters Eli Lilly’s San Diego innovation hub to speed its precision gene-therapy pipeline toward ...

Licensing deal brings Amprion’s misfolded-protein test closer to European trial sites, aiming to speed up neurodegenerative ...

Deal with Singapore’s MuseCell Innovations could bring $300 million in business and 200 jobs to Celularity’s cell platform.

A newly allowed US patent covers the lipid delivery system behind Daewoong’s experimental mRNA platform for reprogramming ...

Fresh off the world’s largest mammalian longevity screen, Longevica names ex-Genentech exec Prasun Mishra to steer science ...

Veradermics posts $819.9m war chest and full slate of late-stage trial data as it races to become first FDA-approved oral ...

A new 10–15 minute series aims to bring clarity and nuance to the big and bold ideas shaping the future of human longevity.

Function Health now lets members feed lab results into ChatGPT, Claude and Perplexity, turning AI answers into ones grounded ...

Alzheimer’s trial needing 760. For a biotech betting everything on one pill, that’s the good kind of surprise.